Novonix Free Cash Flow (FCF) History (NVX)
Novonix reported −$102.4M in free cash flow for fiscal 2025, a decrease of $32.1M from the previous fiscal year, with a free cash flow margin of −1822.48%.
View full Novonix company overviewNovonix free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$102.4M | −$32.1M | — | −1822.48% |
| 2024 | 2024-12-31 | −$70.3M | −$14.9M | — | −1200.75% |
| 2023 | 2023-12-31 | −$55.4M | $57.5M | — | −687.94% |
| 2022 | 2022-06-30 | −$112.9M | −$87.3M | — | −1850.76% |
| 2021 | 2021-06-30 | −$25.6M | −$18.2M | — | −656.86% |
| 2020 | 2020-06-30 | −$7.3M | — | — | −257.04% |
Novonix quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Novonix free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$7.3M to −$102.4M, a net decrease of $95.0M.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Novonix filings at SEC.gov ↗